Background: To distinguish between malignant and benign lesions of the thyroid gland and due to several overlapping histomorphological features and pitfalls in thyroid pathology, there is a need to establish a panel of immunomarkers that could aid in proper diagnosis. This study is intended to investigate the ability of CK-19 & HBME-1 in differentiating between benign and papillary carcinoma thyroid